Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $991.58 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $550.00 | 13 | $0 (2022) |
| ABBVIE INC. | $312.87 | 11 | $0 (2024) |
| Novo Nordisk Inc | $37.33 | 2 | $0 (2023) |
| Forte Bio-Pharma LLC | $31.37 | 1 | $0 (2018) |
| Insulet Corporation | $24.34 | 1 | $0 (2019) |
| Chiesi USA, Inc. | $22.80 | 1 | $0 (2024) |
| IBSA Pharma Inc. | $12.87 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.02 | 4 | ABBVIE INC. ($62.22) |
| 2023 | $287.98 | 10 | AbbVie Inc. ($250.65) |
| 2022 | $56.02 | 3 | Allergan, Inc. ($56.02) |
| 2019 | $391.77 | 11 | Allergan Inc. ($354.56) |
| 2018 | $31.37 | 1 | Forte Bio-Pharma LLC ($31.37) |
| 2017 | $139.42 | 1 | Allergan Inc. ($139.42) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 12/05/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $18.22 | General |
| 10/11/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 10/10/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 10/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $4.38 | General |
| 09/13/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $48.72 | General |
| 06/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $106.67 | General |
| 05/03/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $10.76 | General |
| 04/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 02/25/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $18.81 | General |
| 10/11/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $20.75 | General |
| 10/10/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 08/26/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $19.72 | General |
| 11/19/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| 10/23/2019 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Insulin Pump | ||||||
| 10/03/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| 09/26/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $13.64 | General |
| 08/22/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| Category: Endocrinology | ||||||
| 08/19/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $3.29 | General |
| 05/17/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $6.25 | General |
| 05/05/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $126.58 | General |
About Dr. Linette Rivera, MD
Dr. Linette Rivera, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Doral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1447485446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Linette Rivera, MD has received a total of $991.58 in payments from pharmaceutical and medical device companies, with $85.02 received in 2024. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($991.58).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Doral, FL
- Active Since 05/19/2009
- Last Updated 06/10/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1447485446
Products in Payments
- BOTOX COSMETIC (Biological) $170.93
- NAMENDA XR (Drug) $139.42
- BOTOX (Biological) $44.22
- Ozempic (Drug) $37.33
- Nalocet (Drug) $31.37
- Omnipod (Device) $24.34
- CLEVIPREX (Drug) $22.80
- Tirosint (Drug) $12.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Doral
Dr. Brenda Acosta Ashby, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $468,837
Dr. Krista Gonzales, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $48,175
Dr. Noreen Shaaban, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $8,781
Pascual De Santis, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $2,276